Rybelsus relies on the SOUL trial and class-level semaglutide CV data Switching timing / Transition can occur the day after the last dose of the outgoing drug, with dose titration on the incoming agent GI side effects / Nausea, vomiting, and diarrhea occur with both
In preclinical models, GIP has been shown to decrease food intake and increase energy expenditure therefore resulting in weight reductions, and when combined with GLP-1 receptor agonism, may result in greater effects on markers of metabolic dysregulation such as body weight, glucose and lipids. Incretin hormones are released whenever food is consumed
How to Tell if Your Medication Has Gone Bad Sometimes, your pen will give you a visual warning that it is no longer safe to use
If you want the simplest possible protocol Simplicity has real value
At higher doses, the effects tend to be stronger and more consistent, which is why Wegovy is usually preferred when weight management is the primary goal